Serum autoantibodies against the extracellular region of α6β4 integrin in a patient with dipeptidyl peptidase-4 inhibitor–induced bullous pemphigoid
Authors:
Open Access
- 23 December 2021
- journal article
- Published by Elsevier in JAAD Case Reports
- Vol. 20, 65-68
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (JP18K08296, JP21K08344)
This publication has 10 references indexed in Scilit:
- Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180Frontiers in Immunology, 2019
- A systematic survey of conformational states in β1 and β4 integrins using negative-stain electron microscopyJournal of Cell Science, 2018
- Bullous pemphigoid induced by dipeptidyl peptidase‐4 inhibitors. Eight cases with clinical and immunological characterizationInternational Journal of Dermatology, 2018
- Humoral Epitope Spreading in Autoimmune Bullous DiseasesFrontiers in Immunology, 2018
- Detection and characterization of IgG, IgE, and IgA autoantibodies in patients with bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitorsJournal of the American Academy of Dermatology, 2018
- Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous PemphigoidJournal of Investigative Dermatology, 2016
- Linear IgA/IgG bullous dermatosis reacts with multiple laminins and integrinsEuropean Journal Of Dermatology, 2015
- Antigen Specificity in Subsets of Mucous Membrane PemphigoidJournal of Investigative Dermatology, 2006
- Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severityBritish Journal of Dermatology, 2005
- The Autoantibodies to α6β4 Integrin of Patients Affected by Ocular Cicatricial Pemphigoid Recognize Predominantly Epitopes Within the Large Cytoplasmic Domain of Human β4The Journal of Immunology, 2000